| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Morich Frank serves as a Director at CUE. Across recent SEC filings that breaks down to 1 buy and 0 sells. Those positions are worth an estimated $759K at current prices.
The biggest single holding is CUE (~$759K) as Director. Net of sales, the recent Form 4 record there shows accumulation of 28,000 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 27, 2022 | CUE Cue Biopharma, Inc. | Director | Buy | 28,000 | $3.75 | $105,000.00 | New | -23.3% | +1.3% |